ERANI ALBERT 4
Accession 0001062993-22-014506
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:11 PM ET
Size
22.3 KB
Accession
0001062993-22-014506
Insider Transaction Report
- Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total
- Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total
- Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total - Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total
- Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total
- Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total - Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total
- Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total
- Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total - Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total
- Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total - Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total
- Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total - Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total
- Sale
Class A Common Stock
2022-06-08$5.39/sh−20,000$107,800→ 59,278,027 total - Sale
Class A Common Stock
2022-06-06$5.41/sh−100,000$541,000→ 59,348,027 total - Sale
Class A Common Stock
2022-06-07$5.49/sh−50,000$274,500→ 59,298,027 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.55, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.34 to $5.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4.
Issuer
Organogenesis Holdings Inc.
CIK 0001661181
Related Parties
1- filerCIK 0001074084
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:11 PM ET
- Size
- 22.3 KB